IP Library Granted Patent US 10,077,478
Granted Patent B2
US 10,077,478 · App. 14/383,101 · Granted Sep 18, 2018

Determining paired immune receptor chains from frequency matched subunits

Inventors: Malek Faham (South San Francisco, CA); Mark Klinger (South San Francisco, CA)
Assignee: Adaptive Biotechnologies Corp.
C12Q1/6886C12N15/1034C12Q1/6883C12Q2600/112
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,077,478
App. No.
14/383,101
Granted
Sep 18, 2018
Kind
B2
Abstract

The invention is directed to methods for determining nucleic acids that encode immune receptor chains originating from the same cell, that is, paired immune receptor chains. Methods of the invention comprise high-throughput sequencing of rearranged nucleic acids encoding immune receptors from one or more samples of lymphocytes. In one aspect, from a plurality of subsets of a sample, nucleic acids encoding separate chains of a pair are separately sequenced, wherein the size of the sample and the number of subsets are selected so that the distribution of lymphocytes approximates a binomial model. Paired chains are determined by identifying pairs that appear together or that are entirely absent in the subsets.

Claims (13)

1. A method of determining a profile of likely paired immune receptor chains in a sample containing a plurality of lymphocytes, wherein the sample is obtained from a subject, and wherein the lymphocytes express a repertoire of immune receptor chain pairs, the method comprising the steps of:

(a) partitioning the sample into a plurality of subsets such that each of the subsets comprises at least 1,000 T cells or at least 1,000 B cells;

(b) amplifying VDJ regions and VJ regions of CDR3 sequences of substantially all immune receptor chains in each of the subsets by a single multiplex polymerase chain reaction and sequencing the resulting amplicons to produce a subset list of VDJ regions and VJ regions nucleotide sequences for each of said subsets of step (a);

(c) determining, for each of said subsets, (i) whether or not a first nucleotide sequence encoding a first chain of a likely immune receptor pair in any of the subsets is present in each subset list of nucleotide sequences, and (ii) whether or not a second nucleotide sequence encoding a second chain of a likely immune receptor pair in any of the subsets is present in each subset list of nucleotide sequences; and

(d) producing a profile of a plurality of likely paired immune receptor chains by matching those first and second nucleotide sequences that are present together in at least one subset list and not present separately in other subset lists at all.

2. The method of claim 1 , further comprising the step of repeating said steps (a)-(d) one or more times for another plurality of subsets different from any previous plurality.

3. The method of claim 1 , wherein said immune receptor chains are T cell receptor α chain and T cell receptor β chain.

4. The method of claim 1 , wherein said immune receptor chains are B cell receptor heavy chain variable region and B cell receptor light chain variable region.

5. The method of claim 1 , wherein said sample contains a population of said lymphocytes expressing said pairs of immune receptor chains, and wherein the population has a size and each different lymphocyte of the population has a frequency within the population; and wherein the sample comprises at least 10,000 unique clonotypes.

6. The method of claim 1 , wherein said first immune receptor chain is a TCRγ chain and said second immune receptor chain is a TCRδ chain.

7. The method of claim 1 , wherein said profile of likely paired immune receptor chains comprises at least 100 pairs of nucleotide sequences encoding a first immune receptor chain and a second immune receptor chain and wherein each of said nucleotide sequences has a length in the range of from 30 to 500 nucleotides.

8. The method of claim 7 , wherein said profile comprises at least 1000 pairs of said nucleotide sequences.

9. The method of claim 1 , wherein step (b) generates sequence reads of at least 1000 distinct clonotypes per run.

Assignments (2)
SECURITY INTEREST Recorded Sep 15, 2022
From: ADAPTIVE BIOTECHNOLOGIES CORPORATION
To: ORBIMED ROYALTY & CREDIT OPPORTUNITIES IV, LP
Reel/Frame 061449/0689 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 19, 2016
From: SEQUENTA, LLC
To: ADAPTIVE BIOTECHNOLOGIES CORP.
Reel/Frame 037560/0788 →
Continuity (2)
Provisional Application 61606617 · Mar 5, 2012
Related Publication 20150031043A1 · Jan 29, 2015
Cited By (10)
US 12,234,505 US 12,297,487 US 12,297,488 US 12,351,872 US 12,391,979 US 12,391,980 US 12,449,419 US 12,486,501 US 12,637,706 US 12,709,775